| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |